GMED
Globus Medical, Inc.
NYSEUSDEQUITY
DELAYED
Last price
86.91
▲ 1.24 (1.45%)
MARKET · —
Price
Open
85.67
Prev close
85.67
Day high
87.16
Day low
85.26
Volume
651.82K
Market cap
—
P/E (TTM)
—
52W range
54.15 – 101.40
Trailing performance
Returnvs SPY
1W
+1.18%
+2.5%
1M
+15.23%
+11.5%
3M
+2.72%
-0.4%
6M
-4.06%
-15.1%
YTD
-0.46%
-12.7%
1Y
+43.11%
+23.1%
3Y
+54.73%
-19.4%
5Y
—
—
Price return only. Dividends are not reinvested, so total return on a dividend payer will be higher than shown.
Fundamentals
Market cap—
Enterprise value—
Revenue (TTM)—
Gross profit—
EBITDA—
Net income—
EPS (TTM)—
Free cash flow—
Total cash—
Total debt—
Book value / share—
Shares outstanding—
Float—
Short % of float—
Dividend yield—
Beta (5Y)—
Valuation & profitability ratios
Trailing P/E—
Forward P/E—
PEG ratio—
Price / sales—
Price / book—
EV / revenue—
EV / EBITDA—
Gross margin—
Operating margin—
Profit margin—
Return on equity—
Return on assets—
Debt / equity—
Current ratio—
Fourteen ratios including P/E, PEG, EV/EBITDA, margins and return on equity.
Analyst targets & ownership
Mean target—
High target—
Low target—
Implied upside—
Analyst count—
Consensus—
Strong buy / Buy— / —
Hold—
Sell / Strong sell— / —
Held by insiders—
Held by institutions—
Institutions holding—
Price targets, consensus spread, insider and institutional ownership.
Moving averages & technicals
SMA 10
86.13
+0.91% from price
SMA 20
83.38
+4.24% from price
SMA 50
80.62
+7.80% from price
SMA 100
83.41
+4.19% from price
SMA 200
85.71
+1.41% from price
EMA 12
85.19
+2.02% from price
EMA 26
83.18
+4.49% from price
EMA 50
82.24
+5.67% from price
RSI (14)
60.4
Neutral
MACD (12,26,9)
2.01
Hist 0.34
ATR (14)
2.67
3.07% of price
Realised vol 30D
35.9%
Annualised
Bollinger upper
89.28
20, 2σ
Bollinger lower
77.48
20, 2σ
50 / 200 cross
Death
80.62 vs 85.71
Trend bias
Above 200
+1.41%
Risk profile
Beta vs SPY
0.81
Less volatile than market
Correlation to SPY
0.21
Largely independent
Realised vol 30D
35.9%
Annualised
Market vol 1Y
12.9%
SPY, annualised
Max drawdown 1Y
-22.1%
Peak to trough
Max drawdown 5Y
-47.9%
Peak to trough
ATR 14
2.67
3.07% of price
Beta (reported)
—
5Y monthly, from filing
Options chain
Calls
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Puts
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Every listed expiry, both sides of the book, with volume, open interest and implied volatility.
Headlines
Intuitive Surgical Stock Has Fallen While Its Operating Margin Keeps Widening
Trefis · 19h ago
Here's Why Encompass Health Can Be a Smart Addition to Your Portfolio
Zacks · 21h ago
Here's Why You Should Retain Inogen Stock in Your Portfolio for Now
Zacks · 22h ago
Is it the Right Time to Retain DGX Stock in Your Portfolio?
Zacks · 22h ago
Johnson & Johnson Wins FDA 510(k) Clearance for MONARCH QUEST 3 Update
Zacks · 22h ago
INSP Stock Rallies Nearly 40% YTD: Can Its Growth Story Continue?
Zacks · 22h ago
BrightSpring Stock Up Nearly 59% YTD: Can Its Growth Story Continue?
Zacks · 22h ago
Here's Why You Should Hold Stryker Stock in Your Portfolio for Now
Zacks · 22h ago
PRIVATE STRATEGY · BY QUALIFICATION
The same data. A different seat.
The research you are reading is the input layer for a discretionary options program we run for a small number of qualified investors. Minimum $1,000,000.